Advanced search
Publication Cover
Clinical Pharmacology: Advances and Applications Volume 15, 2023 - Issue
Submit an article Journal homepage
449
Views
2
CrossRef citations to date
0
Altmetric
CASE REPORT

Cefepime-Induced Neutropenia: A Case Report and Literature Review

Somaya Koraysh1 Department of Pharmacy, Hamad Bin Khalifa Medical City, Hamad Medical Corporation, Doha, QatarCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-2743-4496
ORCID Icon,
Junais Koleri2 Department of Infectious Disease, Communicable Disease Center, Hamad Medical Corporation, Doha, Qatar
&
Maisa Ali2 Department of Infectious Disease, Communicable Disease Center, Hamad Medical Corporation, Doha, Qatar
Pages 33-40 | Received 27 Feb 2023, Accepted 13 Apr 2023, Published online: 19 Apr 2023

References

  • Bhatt V, Saleem A. Review: drug-induced neutropenia--pathophysiology, clinical features, and management. Ann Clin Lab Sci. 2004;34(2):131–137.
  • Justiz Vaillant AA, Zito PM. Neutropenia. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2022.
  • Rattay B, Benndorf RA. Drug-induced idiosyncratic agranulocytosis - infrequent but dangerous. Front Pharmacol. 2021;12. doi:10.3389/fphar.2021.727717
  • Andersohn F, Konzen C, Garbe E. Systematic review: agranulocytosis induced by nonchemotherapy drugs. Ann Intern Med. 2007;146(9):657. doi:10.7326/0003-4819-146-9-200705010-00009
  • Coates TD. Drug-induced neutropenia and agranulocytosis. In: UpToDate. Waltham, MA: UpToDate; 2023.
  • O’Connor A, Lopez MJ, Eranki AP. Cefepime. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2022.
  • Post TW. Cefepime. In: UpToDate. Waltham, MA: UpTodate; 2023.
  • Foong KS, Hsueh K, Bailey TC, et al. A cluster of cefepime-induced neutropenia during outpatient parenteral antimicrobial therapy. Clin Infect Dis. 2019;69(3):534–537. doi:10.1093/cid/ciy1112
  • Hernández R, Delpiano L, Amador J, Arias M, Carrasco Delgado J. Neutropenia asociada al uso de cefepime en pacientes pediátricos con fibrosis quística. Rev Chil Infectol. 2019;36(1):112–114. doi:10.4067/S0716-10182019000100112
  • Malincarne L, Francisci D, Martinelli L, Masini G, Baldelli F. A case of severe cefepime-related neutropenia in a 15-year-old patient. Scand J Infect Dis. 2010;42(2):156–157. doi:10.3109/00365540903380503
  • Hettmer S, Heeney MM. Cefepime-induced neutropenia in a teenager. Pediatr Blood Cancer. 2008;51(5):715–716. doi:10.1002/pbc.21664
  • Wong BB, Ko GJ. Neutropenia in patients receiving long-term cefepime therapy for osteomyelitis. Am J Health Syst Pharm. 2003;60(21):2229–2232. doi:10.1093/ajhp/60.21.2229
  • Dahlgren AF. Two cases of possible cefepime-induced neutropenia. Am J Health Syst Pharm. 1997;54(22):2621–2622. doi:10.1093/ajhp/54.22.2621
  • Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239–245. doi:10.1038/clpt.1981.154
  • Holz JM, Chevtchenko AV, Aitullina A. Acute antibiotically induced neutropenia: a systematic review of case reports. Br J Clin Pharmacol. 2022;88(5):1978–1984. doi:10.1111/bcp.15170
  • Johnston A, Uetrecht J. Current understanding of the mechanisms of idiosyncratic drug-induced agranulocytosis. Expert Opin Drug Metab Toxicol. 2015;11(2):243–257. doi:10.1517/17425255.2015.985649
  • Curtis BR. Non–chemotherapy drug–induced neutropenia: key points to manage the challenges. Hematol Am Soc Hematol Educ Program. 2017;2017(1):187–193. doi:10.1182/asheducation-2017.1.187
  • Gatell JM, Rello J, Miro JM, Martinez JA, Soriano E, SanMiguel Garcia J. Cloxacillin-induced neutropenia. J Infect Dis. 1986;154(2):372. doi:10.1093/infdis/154.2.372
  • Jayaweera JAAS, Abeydeera WPH, Ranasinghe GR. Intravenously administered cloxacillin-induced neutropenia with eosinophilia in a patient with infective endocarditis: a case report. J Med Case Rep. 2018;12(1):384. doi:10.1186/s13256-018-1933-3
  • Briggs S, Smith S, Ritchie S, Fitzharris P, Ellis-Pegler R. Late-onset bolus intravenous beta-lactam antibiotic adverse reaction: short-lived symptoms during drug administration and associated laboratory abnormalities. Scand J Infect Dis. 2014;46(1):14–20. doi:10.3109/00365548.2013.849815
  • Berbari EF, Kanj SS, Kowalski TJ, et al. 2015 Infectious Diseases Society of America (IDSA) clinical practice guidelines for the diagnosis and treatment of native vertebral osteomyelitis in adults. Clin Infect Dis. 2015;61(6):e26–e46. doi:10.1093/cid/civ482
  • Cimino C, Allos BM, Phillips EJ. A review of β-Lactam–associated neutropenia and implications for cross-reactivity. Ann Pharmacother. 2021;55(8):1037–1049. doi:10.1177/1060028020975646
  • Chaudhry SB, Veve MP, Wagner JL. Cephalosporins: a focus on side chains and β-Lactam cross-reactivity. Pharm J Pharm Educ Pract. 2019;7(3):103.
  • Uy N, Thiagarajan P, Musher DM. Cephalosporin side chain idiosyncrasies: a case report of ceftriaxone-induced agranulocytosis and review of literature. Open Forum Infect Dis. 2015;2(1). doi:10.1093/ofid/ofv007

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.